Search Orphan Drug Designations and Approvals
-
Generic Name: | Carmustine |
---|---|
Date Designated: | 07/03/2000 |
Orphan Designation: | Treatment of intracranial malignancies. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Direct Therapeutics, Inc. 460 Seaport Court Suite 220 Redwood, California 94063 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-